Internal Medicine, Endocrinology, Diabetes, & Metabolism · Forest Hills, NY
NPI
1083672133
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6860 Austin St, Suite 202
Forest Hills, NY, 11375
Phone (718) 575-9734
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
2,632 services
Medicare patients, 2024
426
Average age 74
Drug cost, 2024
$3.2M
13,158 prescriptions
Company payments, 2025
$2,501
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tooraj Zahedi was code 99214 (office e&m - established), 699 times for 315 patients. In total Tooraj Zahedi billed 2,632 services in 27 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 699 | 315 | $106.07 | $74K |
| 82962 Clinical Chemistry | Office | 478 | 194 | $3.21 | $1,534 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 353 | 217 | $13.79 | $4,869 |
| 76536 Ultrasound - Nonspecific | Office | 209 | 195 | $97.46 | $20K |
| 99442 Telephone Services | Office | 171 | 105 | $72.59 | $12K |
| 95251 Test - Miscellaneous | Office | 112 | 56 | $29.33 | $3,285 |
| 95921 Electrical Nerve Conductivity | Office | 84 | 83 | $78.54 | $6,597 |
| 95923 Electrical Nerve Conductivity | Office | 84 | 83 | $108.21 | $9,090 |
| 93922 Duplex Scan - Extremity Arteries | Office | 78 | 77 | $74.08 | $5,778 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 60 | 25 | $53.42 | $3,205 |
| 99204 Office E&M - New | Office | 58 | 58 | $138.01 | $8,005 |
| 99213 Office E&M - Established | Office | 40 | 38 | $72.14 | $2,885 |
| 96372 Injection Administration | Office | 38 | 24 | $11.77 | $447 |
| 95250 Test - Miscellaneous | Office | 23 | 23 | $132.16 | $3,040 |
| 99223 Hospital E&M - Initial | Facility | 22 | 21 | $151.81 | $3,340 |
By year: 2022 $183K for 2,363 services; 2023 $187K for 2,398 services; 2024 $172K for 2,632 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 478 | 194 | $3.21 | $1,534 |
Medicare prescription drug claims, 2024
In 2024, the drug Tooraj Zahedi prescribed most often to Medicare patients was Pioglitazone Hcl, with 672 prescriptions and refills. In total Tooraj Zahedi wrote 13,158 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 672 | 1,349 | 206 | $6,665 |
| Rosuvastatin Calcium Generic | 642 | 1,373 | 221 | $6,572 |
| Levothyroxine Sodium Generic | 633 | 1,298 | 191 | $6,972 |
| Metformin Hcl Generic | 578 | 1,169 | 178 | $3,487 |
| Atorvastatin Calcium Generic | 386 | 805 | 131 | $3,371 |
| Synthroid Levothyroxine Sodium | 366 | 880 | 108 | $35K |
| Ozempic Semaglutide | 362 | 438 | 73 | $398K |
| Amlodipine Besylate Generic | 320 | 644 | 94 | $1,382 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 292 | 458 | 80 | $76K |
| Losartan Potassium Generic | 286 | 647 | 98 | $2,305 |
| Gabapentin Generic | 285 | 467 | 96 | $1,906 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 256 | 476 | 70 | $88K |
| Novolog Flexpen Insulin Aspart | 247 | 404 | 74 | $50K |
| Mounjaro Tirzepatide | 240 | 261 | 39 | $267K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 235 | 561 | 97 | $25K |
Brand drugs: 4,124 claims; generic drugs: 7,830 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tooraj Zahedi $2,501 ($2,501 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novo Nordisk Inc with $292.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $292 |
| Mannkind Corporation MNKD | 4 | $264 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $257 |
| Medtronic, Inc. MDT | 8 | $228 |
| Amgen Inc. AMGN | 12 | $216 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $173 |
| CeQur Corporation | 1 | $159 |
| Chiesi USA, Inc. | 4 | $108 |
| Insulet Corporation PODD | 4 | $98.61 |
| Corcept Therapeutics CORT | 4 | $86.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.